NCT04684264Completed
Feasibility of the Implementation of Tools for Heart Failure Risk Prediction
Transforming the Primary Prevention Paradigm for Heart Failure: Feasibility of the Implementation of Tools for Heart Failure Risk Prediction
Source: ClinicalTrials.gov · Last updated 20 Mar 2024
Brief summary (registry, in English)
The purpose of this study is to gather information to develop a heart failure screening and prevention program.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 101 (actual)
- First submitted
- 11 Dec 2020
- Start date
- 3 Mar 2021
- Primary completion date
- 30 Aug 2023
- Lead sponsor
- Northwestern University
- Diseases
- Heart failure
- NCT number
- NCT04684264
What you commit to
- Study type: Interventional
- Participants enrolled: 101
- From 3 Mar 2021 to the primary completion date, 30 Aug 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of cardiovascular disease
- Signs and symptoms of heart failure
- Stage 3 or 4 cancer
Other
- Estimated glomerular filtration rate \<45 mL/min/1.73m\^2
- Pregnancy
Who the study is looking for
- 10-year risk of heart failure \>5% based on the PCP-HF equations
- At least one primary care visit in the last 12 months
- At least one additional primary care visit in the last 5 years
- Had cholesterol and glucose checked within the past 5 years
Age in the registry: 30 years to 79 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Northwestern University Department of Preventive Medicine Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.